X

Sign up for Equitymaster's free daily newsletter, The 5 Minute WrapUp and get access to our latest Multibagger guide (2017 Edition) on picking money-making stocks.

This is an entirely free service. No payments are to be made.


Download Now Subscribe to our free daily e-letter, The 5 Minute WrapUp and get this complimentary report.
We hate spam as much as you do. Check out our Privacy Policy and Terms Of Use.
Lupin Ltd Fact Sheet, Lupin Ltd Financial Results - Equitymaster
  • MyStocks

MEMBER'S LOGINX

     
Login Failure
   
     
   
     
 
 
 
(Please do not use this option on a public machine)
 
     
 
 
 
  Sign Up | Forgot Password?  

Lupin Ltd Fact Sheet   (LUPL)

Here is the latest financial fact sheet of Lupin Ltd. For more details, see the Lupin Ltd quarterly results and Lupin Ltd share price and chart. For a sector overview, read our pharmaceuticals sector report.

LUPIN LTD Price History

Price Rs 1,060.9
Mkt Cap Rs m 478,591
Vol '000 97.9
P/E X 18.7
P/CF X 17.4
EPS (TTM) Rs 56.7
% ch % -0.6
No. of shares m 451.14
% ch week % -6.2
% ch 1-mth % -15.1
% ch 12-mth % -28.6
52 week H/L Rs 1,750.0/1,058.8
(As on Jun 23, 2017 (Close))
* Results Consolidated
Excel EXPORT | DO YOU LIKE THESE FACTSHEETS? TELL US!

LUPIN LTD Financials

No. of Mths
Year Ending
12
Mar-12
*
12
Mar-13
*
12
Mar-14
*
12
Mar-15
*
12
Mar-16
*
5-Yr Chart
Click to enlarge
LUPIN LTD EQUITY SHARE DATA
High Rs5336391,0032,0372,127 
Low Rs4055076069041,294 
Sales per share (Unadj.) Rs158.6215.4251.7280.3304.1 
Earnings per share (Unadj.) Rs19.429.441.053.550.4 
Diluted earnings per shareRs19.229.140.753.350.3 
Cash flow per share (Unadj.) Rs24.536.846.863.160.7 
Dividends per share (Unadj.) Rs3.204.006.007.507.50 
Adj. dividends per shareRs3.173.975.967.477.49 
Dividend yield (eoy) %0.70.70.70.50.4 
Book value per share (Unadj.) Rs89.8116.3154.6197.4243.8 
Adj. book value per shareRs89.0115.4153.6196.7243.5 
Shares outstanding (eoy) m446.64447.53448.38449.49450.58 
Bonus/Rights/Conversions  ESOP-ESOPESOP- 
Price / Sales ratio x3.02.73.25.25.6 
Avg P/E ratio x24.119.519.627.533.9 
P/CF ratio (eoy) x19.115.617.223.328.2 
Price / Book Value ratio x5.24.95.27.47.0 
Dividend payout %16.513.614.614.014.9 
Avg Mkt Cap Rs m209,474256,435360,767660,975770,740 
No. of employees `000NANANA14.216.4 
Total wages/salary Rs m9,69512,66614,64717,47321,077 
Avg. sales/employee Rs ThNMNMNM8,874.38,379.6 
Avg. wages/employee Rs ThNMNMNM1,230.71,289.0 
Avg. net profit/employee Rs ThNMNMNM1,692.71,388.7 
LUPIN LTD INCOME DATA
Net Sales Rs m70,82996,413112,866125,997137,016 
Other income Rs m1442791,1652,3981,877 
Total revenues Rs m70,97396,692114,031128,395138,893 
Gross profit Rs m14,44722,70030,02836,19637,535 
Depreciation Rs m2,2753,3222,6104,3474,635 
Interest Rs m35541026798446 
Profit before tax Rs m11,96119,24628,31734,14834,330 
Minority Interest Rs m-199-263-331-412-88 
Prior Period Items Rs m20000 
Extraordinary Inc (Exp) Rs m00000 
Tax Rs m3,0875,8429,6229,70411,536 
Profit after tax Rs m8,67713,14218,36424,03222,707 
Gross profit margin %20.423.526.628.727.4 
Effective tax rate %25.830.434.028.433.6 
Net profit margin %12.213.616.319.116.6 
LUPIN LTD BALANCE SHEET DATA
Current assets Rs m43,42351,43161,00578,32497,790 
Current liabilities Rs m31,20330,06926,29637,29253,872 
Net working cap to sales %17.322.230.832.632.1 
Current ratio x1.41.72.32.11.8 
Inventory Days Days8974697385 
Debtors Days Days92838077121 
Net fixed assets Rs m26,89428,03630,01932,96186,379 
Share capital Rs m893895897899901 
"Free" reserves Rs m37,65649,55467,92285,830105,735 
Net worth Rs m40,12952,04269,31688,741109,844 
Long term debt Rs m4,3302,4711,5101,01853,739 
Total assets Rs m79,35489,139102,060131,377224,378 
Interest coverage x34.747.9107.3349.177.9 
Debt to equity ratio x0.10000.5 
Sales to assets ratio x0.91.11.11.00.6 
Return on assets %11.415.218.318.410.3 
Return on equity %21.625.326.527.120.7 
Return on capital %27.335.639.937.721.2 
Exports to sales %42.844.850.746.449.1 
Imports to sales %10.78.78.68.87.4 
Exports (fob) Rs m30,32943,15757,17758,48267,244 
Imports (cif) Rs m7,6088,3919,65411,05710,199 
Fx inflow Rs m32,44444,74963,07662,59371,405 
Fx outflow Rs m11,38913,82016,48016,59217,807 
Net fx Rs m21,05530,92946,59646,00153,598 
LUPIN LTD CASH FLOW
From Operations Rs m 5,600 12,510 20,039 27,331 -3,690 
From Investments Rs m -7,413 -5,219 -8,585 -10,545 -69,434 
From Financial Activity Rs m 1,089 -6,628 -8,571 -1,969 58,126 
Net Cashflow Rs m -724 663 2,883 14,817 -14,998 
* Results Consolidated
Source: Company Annual Reports, Regulatory Filings, Equitymaster

Share Holding

Indian Promoters 46.6%
Foreign collaborators 0.2%
Indian inst/Mut Fund 11.3%
FIIs 31.9%
ADR/GDR 0.0%
Free float 10.1%
Shareholders 98,259
Pledged promoter(s) holding 0.0%
 

Company Information

REGD OFF 159, C.S.T. Road, Kalina, Santacruz (E), Mumbai - 400 098
E-MAIL rajvardhansatam@lupinpharma.com WEB www.lupinworld.com
TELEPHONE (022) 6640 2323 FAX (022) 2652 8806
SECTOR PHARMACEUTICALS GROUP MISCELLANEOUS
TR AGENT In-house
AUDITOR Deloitte Haskins & Sells
CHM: D. B. Gupta COMP SEC: R. V. Satam YEAR OF INC: 1983 BSE CODE: 500257 FV (Rs): 2 DIV YIELD (%): 0.7

More Pharmaceuticals Company Fact Sheets:   ALKEM LABORATORIES  WYETH LTD  SANOFI INDIA  BIOCON LTD  WOCKHARDT LTD.  

Compare LUPIN LTD With:   ALKEM LABORATORIES  WYETH LTD  SANOFI INDIA  BIOCON LTD  WOCKHARDT LTD.  

Compare LUPIN LTD With:   MYLAN (US)  ACTAVIS (US)  ADCOCK INGRAM (S. Africa)  TEVA PHARMA (Israel)  



Today's Market

Global Share Markets End the Week on a Dull Note(RoundUp)

Global financial markets ended the week on a dull note. This was on back of the Federal Reserve's release of its May 2-3 policy meeting minutes.

Views on news

Lupin: Decline in US Business Impacts Overall Growth (Quarterly Results Update - Detailed)

May 29, 2017

Currency fluctuation and one time provision impacts operating margins.

Lupin: US Business Drives Growth (Quarterly Results Update - Detailed)

Mar 8, 2017

Lupin has announced its 3QFY17 results. Net sales have grown by 31.5% YoY and net profits have surged by 20.7% YoY. Here is our analysis of the results.

Lupin: Key Products Drive US growth (Quarterly Results Update - Detailed)

Sep 12, 2016

Lupin has announced its 1QFY17results. Net sales have grown by 40% YoY and net profits have surged by 55.1% YoY. Here is our analysis of the results.

Biocon: Lower Licensing Income Leads to Muted Growth for the Quarter (Quarterly Results Update - Detailed)

Jun 23, 2017

Net Profit lower due to exceptional items in the previous year.

Sun Pharma: Price Erosion in US Impacts Growth (Quarterly Results Update - Detailed)

May 30, 2017

US markets decline while other geographies grow in the quarter.

More Views on News

Most Popular

A Pharma IPO in a Market That Loves IPOs but Hates Pharma(The 5 Minute Wrapup)

Jun 15, 2017

Tomorrow comes the IPO of Eris Lifesciences. How will a pharma IPO do in this market?

Bitcoin at $10,000?(Vivek Kaul's Diary)

Jun 14, 2017

Whether you're Venezuela or China or in India or the US...and you want to protect your wealth, you need real money. All the government has on offer is funny money.

Get Ready for Commodity Options!(Daily Profit Hunter)

Jun 16, 2017

Commodity options trading is one step closer to reality. Learn how to take advantage of this tremendous opportunity.

Walter Schloss' Investing Record(Chart Of The Day)

Jun 17, 2017

In a market full of one-hit-wonders, this investor obviously had a formula that worked. And through the think-and-thin of the market.

11 Hidden Costs Associated With Your Home Loan(Outside View)

Jun 16, 2017

Various costs associated with a home loan.

More

TRACK LUPIN LTD

  • Track your investment in LUPIN LTD with Equitymaster's Portfolio Tracker. Set live price alerts, get research alerts and more. Get access now...
  • Add To MyStocks

MORE ON LUPIN LTD

LUPIN LTD - ADCOCK INGRAM COMPARISON

COMPARE LUPIN LTD WITH

MARKET STATS